retatrutide 1mg vs. Tirzepatide Retatrutide - GLP-1 / GIP

Designed to support healthy gutbrain signaling that influences fullness and appetite

GLP-1RAs exert cardioprotective effects through multiple direct and indirect mechanisms, including: Effective control of major CV risk factors (type 2 diabetes, obesity) and slowing of CKD progression

Not changing eating habits during treatment If tirzepatide was your entire weight management strategy, meaning you ate whatever you wanted just in smaller amounts because the medication killed your appetite, you have a problem

Includes DEXA tracking, physician consultations, and medication

Berberine Activates the -Catenin/TCF4 Signaling Pathway by down-Regulating MiR-106b to Promote GLP-1 Production by Intestinal L Cells